FDA clears Night Shift therapy


Advanced Brain Monitoring has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for Night Shift, a therapy for positional obstructive sleep apnoea.

Worn on the back of the neck, Night Shift begins to vibrate when users begin to sleep on their back and slowly increases in intensity until a position change occurs. Night Shift is also an intelligent, interactive monitor that allows users to track its effect on snoring and sleep quality. Clinical study results showed that 89% of participants responded to Night Shift therapy, with the majority experiencing improved sleep quality, reduced loud snoring and improvements in sleep apnoea symptoms.

“In our study we found that 70% of individuals with obstructive sleep apnoea are at least twice as severe while sleeping on their back and may benefit from Night Shift therapy,” states Daniel Levendowski, principal investigator for the study. Most snore more loudly when sleeping on their back, an annoyance that interrupts the sleep of the bed partner.

Night Shift is immediately available through an Indiegogo crowdfunding campaign until June 22. The campaign allows participants to obtain the Night Shift at a substantially discounted price and includes a number of additional benefits.

(Visited 22 times, 1 visits today)